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The natural history of autologous fistulas as
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Marc H. Glickman, MD, Norfolk, Va
Background: Patients on hemodialysis depend on durable, easily maintained vascular access. The autologous arterio-
venous fistula (AVF) has been the gold standard since the introduction of the Brecia-Cimino fistula in 1966 and is echoed
in the current Kidney Disease Outcomes and Quality Initiative (KDOQI) guidelines. The purpose of this study is to
determine the natural history of AVF in patients requiring first-time permanent access in a large academic vascular surgery
practice.
Methods: We performed a retrospective review of patients undergoing new access creation from January 1, 2005 to June
30, 2005. The study group consisted of patients with no prior permanent access that underwent AVF creation.
Categorical data was compared using 2 analysis, nominal data was compared using Student t-test, and patency was
determined by Kaplan-Meier curves.
Results: During the 6-month period, there were 80 first time AVF creations. The majority of patients were male (69%),
African American (55%), and a history of diabetes (55%) and hypertension (96%). Seventy-five percent of patients were
already undergoing hemodialysis via catheter access. Seventy-six percent of patients underwent preoperative veinmapping
with a mean vein diameter of 3.1 mm. Twenty-six radiocephalic AVF (RCAVF) and 54 brachiocephalic AVF (BCAVF)
were created with a mean follow-up of 278 days. At the end of follow-up, 38 (48%) AVFwere being used for hemodialysis
and only nine (11%) matured without the need for additional intervention. Mean time for AVFmaturation was 146 days.
Thirty AVF (37%) were abandoned, 16 (20%) of which were primary failures. Mean time to abandonment was 162 days.
Twelve (15%) AVF remained patent but were never cannulated. The intervention rate was 1.33 interventions/patient/
year and 75% of interventions were percutaneous. Kaplan-Meier analysis determined primary, primary-assisted, and
secondary patency was 36%  8.3, 55%  6.5, and 55%  6.5 at 1 year, respectively. Cumulative functional patency was
63% at 1 year.
Conclusions: In patients receiving a first time permanent access, we found that the majority were AVF and they resulted
in low primary patency rates at 1 year and long maturation times. KDOQI encourages AVF creation in order to increase
AVF use for dialysis, but the strategy of simply increasing the number being created may not lead to the desired result and
potentially lead to an increase in catheter dependence. (J Vasc Surg 2008;47:415-21.)Effective and durable permanent hemodialysis access
has been the goal of access surgeons since the introduction
of the Scibner shunt in 19601 and Brescia-Cimino fistula in
1966.2 The National Kidney Foundation (NFK) began the
Dialysis Outcomes and Quality Initiative (DOQI) in 1995,
now referred to as the Kidney Disease Outcomes and Quality
Initiative (KDOQI), which published a large evidence-based
set of clinical guidelines to help improve healthcare out-
comes among patients with end stage renal disease
(ESRD). One major focus of KDOQI is optimal arterio-
venous (AV) access management, which has lead to the
creation of the National Vascular Access Improvement
Initiative (NAVII) and its Fistula First campaign.3
KDOQI makes it clear that all patients with stage IV or
stage V chronic kidney disease (CKD) who opt for hemo-
dialysis should undergo autologous fistula creation. In or-
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doi:10.1016/j.jvs.2007.10.041der to preserve viable access sites, they recommend a radio-
cephalic arteriovenous fistula (RCAVF) as the first and best
option. If not feasible, then a brachiocephalic arteriovenous
fistula (BCAVF), followed by a basilic vein transposition
(BVT) should be created in the non-dominant arm. Pros-
thetic arteriovenous bridge grafts (AVG) and tunneled
dialysis catheters are mentioned as last resorts in patients
with no autologous options. These recommendations are
based upon available data that suggests that AVF have
superior patency, fewer complications, require fewer re-
interventions, and ultimately improve patient survival.3
Since the inception of KDOQI, there has been a signif-
icant increase in AVF creation4 and a goal of 65% preva-
lence of AVF utilization for hemodialysis by 2009 is set
forth in the most recent KDOQI revision.3 With the in-
creased number of AVF creations, a measurable reduction
in morbidity and mortality was anticipated. However, pub-
lished data from the United States Renal Data System
(USRDS) reported that the number of hospital admissions
for AV access infections has continued to increase every
year and mortality has remained unchanged.5 This study
was undertaken to determine the natural history of AVF
created in a large, experienced academic vascular surgery
practice performing approximately 750 new access proce-
dures per year.
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After obtaining approval from the Eastern Virginia
Medical School Institutional Review Board, we used the
CPT codes 36818, 36819, 36820, 36821, and 36825 to
query the practice’s billing database and generate a list of
patients who underwent AV access surgery between Janu-
ary 1, 2005 and July 30, 2005. Only first-time AVF cre-
ations were included in the review. Patients who received a
prosthetic AV bridge graft or had undergone prior AV
access surgery were excluded from the analysis. The pres-
ence of a temporary or cuffed dialysis catheter was not a
cause for exclusion.
The office and hospital charts were reviewed for patient
demographics, pertinent medical history, physical exam
findings, preoperative imaging studies, and findings from
the postoperative follow-up. Operative notes were re-
viewed for relevant procedural findings and complications.
All postoperative interventions were reviewed for indica-
tion, procedure type, and outcome. The information was
de-identified and recorded in a password protected data-
base.
All preoperative evaluations, procedures, postoperative
evaluations, and interventions were performed by one of
the 14 board-certified vascular surgeons or the one board-
certified transplant surgeon in the practice. AVF creation
was the preferred procedure for first time access patients,
but there was no standard selection algorithm used by the
surgeons in the practice. Patients were screened for creation
of a RCAVF, BCAVF, or BVT, though no one received a
BVT in this cohort. Forearm BVT or proximal radial artery
AVF are not routinely utilized by the practice.
Patients were initially seen during an outpatient visit
and examined for vein adequacy. If a patient appeared to
have adequate venous anatomy on examination, they were
scheduled for AVF creation and at the time of the proce-
dure, the venous anatomy was re-assessed by passing dila-
tors proximally via the veinotomy. If the vein segment did
not accommodate at least a 3mm dilator, then another vein
segment was explored or an AVG creation was performed.
If the venous anatomy appeared inadequate on the in office
examination, then preoperative vein mapping was per-
formed in either the hospital or office noninvasive labora-
tory, both of which are Intersocietal Commission for the
Accreditation of Vascular Laboratories (ICAVAL) certi-
fied. Vein mapping was performed in the supine position
with the head of the bed at a 30-degree incline without the
use of a tourniquet or warm soaks. Each vein segment was
measured at multiple points along its length. Vein mapping
results were reviewed by the operating surgeon and used at
their discretion when deciding the type of access to be
created.
All initial operations were performed in the operating
room, and anastomoses were fashioned either with a run-
ning nonabsorbable suture, or in an interrupted manner
with self-closing metal clips (U-CLIP, Medtronic, Minne-
apolis, Minn). Postoperative interventions took place inone of three venues: an operating room, a hospital-based
endovascular suite, or an office-based endovascular suite.
A functional AVF was defined as a fistula being used for
at least one successful hemodialysis treatment, and a patent
AVF was defined as having a palpable thrill or a bruit on
auscultation. An AVF was considered abandoned if it re-
quired a major revision, including creation of a new anas-
tomosis or placement of a jump graft, required ligation, or
if a new access was required at a new site. An AVF requiring
a patch angioplasty revision was not considered abandoned.
Postoperative interventions were categorized as open or
percutaneous, and included balloon angioplasty, mechani-
cal thrombectomy, stent deployment, vein branch ligation
or embolization, and patch angioplasty with either an au-
tologous or prosthetic patch.
The primary endpoints included AVF abandonment,
renal transplantation, death, or the time measurement of
patency. Primary patency was defined as the interval from
AVF creation until abandonment, intervention, or the time
of measurement of patency as recommended in the stan-
dards for reporting by Sidawy et al.6 Primary-assisted pa-
tency was defined as the interval from AVF creation until
thrombosis, abandonment, or the time of measurement of
patency, including the time after interventions performed
on a patent AVF.6 Secondary patency was defined as the
interval from AVF creation until abandonment or the time
of measurement of patency, including the time after all
interventions.6 The cumulative functional patency was de-
fined as the interval from when the AVF was cannulated
until abandonment or the time of measurement of patency,
including the time after any intervention to maintain or
reestablish function. Primary failure was defined as aban-
donment of an AVF without ever being cannulated or
intervened upon. The data was analyzed using MedCalc
(Mariakerke, Belgium) statistical software. Categorical data
was compared using 2 analysis, nominal data was com-
pared using Student t test, and P  .05 was considered
statistically significant. Kaplan-Meier survival curves were
used to determine the patency of AVF and log rank testing
was used to compare curves.
RESULTS
Demographics. A total of 377 patients underwent AV
access creation from January 1, 2005 through June 30,
2005 and patient selection is depicted in Fig 1. Demo-
graphics of the study group are listed in Table I. At the time
of AVF creation, 78% of patients were being dialyzed with
a cuffed or noncuffed central venous catheter, and this was
located on the contralateral upper body in 71% of patients.
Preoperative vein mapping was performed in 76% of pa-
tients and the mean vein diameters were determined for the
vein segments used for fistula creation (Table II). Biphasic
arterial waveforms were documented on upper extremity
arterial duplex examination performed at the time of vein
mapping in all arteries chosen for fistula creation. Upper
extremity artery diameters were not measured.
Operative data. Of 119 first-time access patients, 80
received an AVF and 39 received an AVG. The outcomes of
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RCAVF (33%) and 54 BCAVF (67%) created over the
6-month period.RCAVFwere created in 40%ofmale patients
and 16% of female patients (P .06). BCAVFwere created in
60% of males and 84% of females (P NS). Construction of
the anastomosis was performed using a continuous nonab-
sorbable suture in 66% of cases and self-closing metal clips in
the remainder. All 14 surgeons participated in access creation
operations with an average of 5.3  2.8 procedures per
surgeon in this cohort during the 6-month period of study.
Every surgeon in the group has at least 5 years of post-
fellowship practice experience with the majority having 10
years of experience or greater.
Follow-up. The mean follow-up was 278 days and
ranged from 13 to 570 days. Outcomes were categorized as
Fig 1. Stratification of all patients who underwent hemodialysis
access surgery from January 1, 2005 to June 30, 2005. Only the
patients who underwent autologous arteriovenous fistula creation
as a first time access procedure were fully reviewed (n  80).
Table I. Patient demographics and clinical characteristics
of 80 patients undergoing first-time AVF creation
Variable* No of patients (%)
Total patient number 80 (100)
Gender
Male sex 55 (69)
Ethnicity
Caucasian 31 (39)
African American 44 (55)
Hispanic 2 (2.5)
Asian/Pacific Islander 3 (3.5)
Comorbidities
Diabetes 44 (55)
Hypertension 77 (96)
Tobacco use 25 (31)
ESRD on dialysis 60 (75)
AVF, Autologous arteriovenous fistula; ESRD, end stage renal disease.
*Mean patient age, 59.7 y.functioning, abandoned, and indeterminate as defined inthe methods section. Thirty-eight AVF (48%) were func-
tional at the end of follow-up and included 12 RCAVF
(32%) and 26 BCAVF (68%), which meant that the AVF
was the being successfully used for hemodialysis treat-
ments. In the functional cohort, nine patients (11%) re-
quired no intervention to achieve and maintain function of
the AVF, whereas 29 (36%) patients required at least one
intervention. The overall mean time to first cannulation was
146 days, and the mean time to first cannulation was
significantly shorter in patients with a BCAVF (129 days )
compared with 187 days for RCAVF (P  .03). There was
no statistical difference in length of time to the first cannu-
lation if a patient required precannulation intervention.
Thirty AVF (37%) were abandoned 16 (20%) had pri-
mary failures, four (5%) failed after intervention but were
never cannulated, and 10 (12.5%) functioned for prior to
abandonment. The mean time to abandonment was 162
days for primary failure and 266 days for all other failures.
The reasons for abandonment are listed in Table III. Aban-
doned AVF tended to have smaller mean vein diameters
when compared with functional AVF, but this did not reach
statistical significance (2.8 mm versus 3.3 mm, respectively,
P  .07). The majority of abandoned AVF were BCAVF
(60%), but this was not statistically significant. Twelve AVF
(15%) were patent on the last documented physical exam
but had never been cannulated and were considered inde-
terminate. Of these, four patients remained free from he-
modialysis, five patients died, one patient underwent renal
transplantation, and two patients continued hemodialysis
via a dialysis catheter for unclear reasons.
Forty-five patients underwent a total of 81 interven-
tions during the follow-up period, 75% of which were
percutaneous and the intervention rate was 1.33 interven-
Table II. Reasons for abandonment of AVF created in
patients who had never had prior permanent access
Reason for abandonment Number*
Inadequate dialysis 4
Poor maturation 10
Thrombosis 15
Procedural complication 1
AVF, Autologous arteriovenous fistula.
*Total number of abandoned AVF  30.
Table III. Reasons for abandonment of AVF created in
patients who had never had prior permanent access
Reason for abandonment Number*
Inadequate dialysis 4
Poor maturation 10
Thrombosis 15
Procedural complication 1
AVF, Autologous arteriovenous fistula.
*Total number of abandoned AVF  30.tions per patient year. The types of interventions are listed
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assisted patency, and secondary patency were 36%  8.3,
55%  6.5, and 55%  6.5, respectively (Fig 2). The
cumulative functional patency, where patency begins at the
time of first successful cannulation, was 63%  7 at 1 year
(n  55), with no difference between the RCAVF and the
BCAVF groups.
DISCUSSION
In 1997, the National Kidney Foundation published
the first version of the KDOQI guidelines, which was
meant to decrease practice variations among hemodialysis
units in the United States and improve patient care. Vascu-
lar access management was one of four original topics, and
it recommended the use of AVF in all hemodialysis depen-
dent patients. The most current version of the KDOQI
guidelines puts forth a goal of 65% prevalence of AVF use in
the hemodialysis units in the United States by 2009. Since
introduction of KDOQI, vascular access surgeons have
increased the number of AVF being created.4,7,8 It is
assumed that this will increase the portion of AVF in use,
yet this result has not yet been reported and its impact on
morbidity and mortality remains to be seen.
This review focuses on patients presenting for a first-
time access creation and characterizes the natural history of
first-time AVF and the majority (66%) of first-ever access
creations in our experience were autologous fistulas. The
portion of AVF that were RCAVF was lower than that of
BCAVF and is similar to the findings of Berman et al.9 This
is likely due to the fact that a decreased number of female
patients receive a RCAVF and, as published elsewhere, is
believed to be due to the smaller vessel diameters often
found in female patients.9-12 The overall lower number of
RCAVF being created may also explain the lower number
of functional RCAVF compared with BCAVF at the end of
the follow-up period. No basilic vein transpositions were
performed in this patient population, but it is considered an
option by the surgeons in the practice. Basilic vein transpo-
sitions were certainly a second option when the initial AVF
was abandoned.
Our mean vein diameter of 3.1 mm was an acceptable
Table IV. Intervention performed on patients with a first
time AVF stratified by type and number performed
Type of intervention n
Percutaneous
Diagnostic fistulogram alone 17
Balloon angioplasty 41
Coiling of branch vein 4
Open
Distal revascularization interval ligation 1
Ligation of branch vein 7
Open thrombectomy 2
Patch angioplasty 4
Superficialization of vein 3
There were a total of 81 interventions performed in 45 patients.size for AVF creation. Silva et al recommended a veindiameter of at least 2.5 mm for adequate AVF creation and
reported a 1-year cumulative AVF patency of 83%.8
Mendes et al reported that only 16% of AVF created with a
vein of less than 2 mmmatured compared with 76% of AVF
created with a vein of 2 mm.13 Rooijens et al reported a
1-year primary patency of 33% in RCAVF constructed with
vein less than 1.6mm in diameter.14We did identify a trend
of failure when AVF were created with smaller mean vein
diameters in abandoned fistulas, but this did not reach
statistical significance perhaps due to our small sample size.
Our AVF primary failure rate was 20% and a majority of
failures were due to thrombosis that is similar to other
published reports.15,16 Our 1-year primary patency was
lower than the primary patency rates reported in the liter-
ature, which ranged from 55% to 78%.9,10,16-20 However,
our 1-year primary-assisted patency and secondary patency
were comparable with the 1-year secondary patencies in the
literature, which ranged from 54% to 71%.10,16,21 Our
primary-assisted and secondary patencies were identical
because only three AVF were salvaged after thrombosis and
the majority patients with a thrombosed AVF received new
access at a new site. The improved primary-assisted and
secondary patency indicates salvage was possible, but a total
of 83 interventions were performed to gain this modest
increase.
The reason for the low primary patency seen in our
cohort compared with the literature might be explained by
an aggressive approach to creating autologous fistulas. As
previously mentioned, our mean vein diameter was 3.1
mm, but patients had an AVF creation with a vein diameter
as small as 1.3 mm. This may have increased our AVF
creation rate to match the KDOQI prevalence goals, but
using smaller vein diameters increases the failure rate.
Relying on traditional patency does not take into ac-
count the functional status of the fistula and overestimates
Fig 2. Kaplan-Meier survival curves of patients who underwent
creation of an autologous arteriovenous fistula (AVF) for a first
time access surgery. Note that the primary-assisted and secondary
patency curves are not significantly different.the number of “working” fistulas at 1 year. We had several
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others whose AVF required more than a year to mature, yet
they are included as “working” in a Kaplan-Meier tabula-
tion. The cumulative functional patency removes primary
failures and time to maturation from the patency calcula-
tion. Our 1-year cumulative functional patency was 63%
and demonstrates that even if an AVF was successfully used
for hemodialysis, only two-thirds were functioning after 1
year. This may seem acceptable in regards to the KDOQI
standards, but over half of the AVF never achieved a func-
tional status.
Our AVF were cannulated in an average of 148 days,
which is substantially longer than other published reports.
Rayner et al reviewed the results from the Dialysis Out-
comes and Practice Patterns Study (DOPPS) and found a
median cannulation time for AVF of 98 days in the United
States.22 Allon et al reported an average cannulation time
87 days for AVF versus 18 days for AVG (P  .001).23 In
addition, our findings show that mean time to primary
failure for our cohort was 162 days. Our prolonged time to
cannulation was not expected and might be initially ex-
plained by AVF creation being performed in patients who
have inadequate anatomy. However, if this was the case,
then AVF with inadequate anatomy would be expected to
fail rather than take longer to mature.14 This prolonged
time to cannulation might be a result of our follow-up
routine, which includes an initial 4-week postoperative visit
for all patients to examine the AVF and the incisions,
followed by 4- to 6-week intervals until deemed ready for
use. Once deemed ready for use, the patient receives a
written order to allow cannulation, which he/she takes to
the dialysis center and the dialysis center staff will cannu-
late. There are several potential factors that might explain
the long time interval till cannulation, but we do not have
enough data to make a definitive statement.
These results suggest that patient selection criteria for
AVF creation in our current practice may not be appropri-
ate and our postoperative follow-up inadequate. New ac-
cess algorithms are required for both the preoperative and
postoperative evaluation of the hemodialysis dependent
patient in order to optimize access use and minimize mor-
bidity. Unfortunately, our study did not reveal any demo-
graphics or anatomical factors that might have better pre-
dicted AVF abandonment, except perhaps for vein size. On
the other hand, there seems to be opportunity for improved
postoperative management. The long time interval for
abandonment suggests that rigorous follow-up is necessary
with set time intervals to achieve maturation or consider
abandonment. There is some literature to suggest regular
screening duplex ultrasounds may improve patency in
AVG,24 but there have been no randomized controlled
trials to examine routine duplex ultrasounds of AVF. Dial-
ysis dependence continues to be a growing problem and
more patients will become catheter dependent while we
wait for AVF maturation. Referral for access creation 6
months prior to the start of hemodialysis is recommended
in KDOQI3, but this has not been a common experience inour practice and is an aspect of patient care that can be
improved upon.
The majority of our patients present for access evalua-
tion following institution of hemodialysis via indwelling
catheters. AVF creation seems to sentence these patients to
catheter dependence for an additional 5 months if not
longer. We did not evaluate whether any morbidity or
mortality was associated with the increased time of catheter
dependence, but there are several published reports that
have examined this issue. Lee et al reported a 50% incidence
of catheter related bacteremia at 6 months.25 Allon et al
showed the relative risk of death was 3.43 over a 1 year
interval when patients dialyze using a catheter compared
with an autologous fistula.26 Thus, any patient on dialysis
who receives an AVF will remain catheter-dependent for
significant time intervals and be exposed to greater risk.
CONCLUSIONS
A high AVF creation rate is possible in the KDOQI era,
but this does not necessarily translate into high AVF utili-
zation. First, we have demonstrated that if an AVF was
successfully used for hemodialysis, it required an average of
5 months to cannulation. Second, even in the best of
circumstances in which a patient is undergoing a first-time
access procedure, many AVF failed and of those that func-
tion only two-thirds are working at the end of 1 year.
Adherence to the KDOQI strategy may increase autolo-
gous fistula creation, but in our experience, this has not
resulted in increase AVF utilization and rather prolonged
catheter-dependence while awaiting maturation and addi-
tional procedures.
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Dr Mellick T. Sykes (San Antonio, Tex). Dr Biuckians and
his mentors in Norfolk are to be commended for this study, which
analyzes a 6-month series of hemodialysis access creation in the
KDOQI – Fistula First era. The specific focus is the natural history
of autologous fistulas created as first-time hemodialysis access
utilizing the National Kidney Foundation’s DOQI guidelines.
The fate of these 80 study patients over the first postop year is
grimly familiar to members of Southern Vascular. Summarizing
the take-home points,
● “Early referral” is a myth, with 4/5 patients already on catheter
dialysis before referral.
● Despite K/DOQI enthusiasm, at 1 year after fistula creation:
X 40% (32/80) of fistulas have never been used – 25% (20/80)
because they failed primarily (16) or after an intervention
before use (4); 15% (12/80) because the patient died or
found another solution although the fistula was patent.
X 13% (10/80) were used at least once, but abandoned despite
interventions
X 48% (38/80) (less than half) were functional: (11% (9/80)
worked w/o intervention – the “perfect” fistula; 37% (29/
80) worked at the cost of 50 interventions in this subgroup,
and 113 additional interventions in the original group of 80
● Maturation time was slow, interventions frequent, actual suc-
cessful use the minority:
Is this the future? Is this the maintenance-free life that the
KDOQI brochures depict? Have we bought swamp land in Flor-
ida? This does not seem intuitively different than the pre-KDOQIThe authors conclude that (1) successful AVF maturation is
slower than previously reported, with a significant failure rate
despite aggressive intervention; (2) that a new paradigm may be
necessary; and (3) that KDOQI probably does not have the an-
swer. But have they – or any of us – really read the KDOQI fine
print?
I must say that I am not a huge fan of KDOQI:
● I resent directives from non-surgeons and nurses, who I picture
sifting papers in a board room and directing surgical judgment
from afar.
● I believe that KDOQI “scorecards” are unprofessional and
embarrassing.
● I do not think that vein-at-any-cost is best for the patient, and
take secret pleasure, if no forearm veins are evident, in placing a
good old-fashioned loop graft like God intended.
● I believe that KDOQI has replaced the promiscuous use of
prosthetic grafts by the equally promiscuous use of central
catheters and percutaneous intervention – by radiologists, neph-
rologists, and vascular surgeons alike.
However, the KDOQI recommendations simply represent a
classic and early example of the effect of evidence based medicine
can and will have on our specialty.
We created it: Members of this Society were the vascular
surgeons on the 2000 and 2006 work groups. KDOQI brochures
quote our literature. They simply summarize what is available out
there. If we believe we have a better vascular access mousetrap, we
only need publish it. They cannot read our minds!
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lines reflect common practice wisdom, and recognizes the problems
noted in this paper: noting that “ theWorkGroup recognizes that in
some cases, the “fistula first at all costs” approachmay not be themost
cost-effective or optimal for each individual. A functional fistula is the
goal, not the insertion of a fistula with a poor chance at maturing. A
graft can be used as a “planned bridge” to a fistula ”1
Questions for the authors:
1. We have found open revision more lasting than endovascular
interventions, particularly in peri-arterial stenosis. Could you
comment?
2. How did this group compare with AVGs created at the same
time?
3. What is your protocol for follow-up? Who followed the patient,
and how? We now duplex fistulas monthly until use;
4. Who decided when to cannulate? When to intervene? When to
abandon a site?
5. In particular, how do you explain the unusual delay in cannu-
lation in your series? Were patients simply lost in the system?
6. Finally, what modifications do you recommend be made in the
DOQI guidelines?
I commend the authors for a lucid presentation of this impor-
tant data.
Dr Andre Biuckians. Thank you for those comments. In
regards to your first question, a majority of the revisions performed
were percutaneous but when we compared abandoned fistulas with
functioning fistulas, functioning fistulas did receive some type of
open revision more often. However, we did not analyze whether
open or percutaneous interventions resulted in improved out-
comes in this series. The practice prefers percutaneous interven-
tions at the time of the diagnostic fistulogram and the fact that a
majority of fistulas in the abandoned group received only a percu-
taneous intervention may be a reflection of unsalvageable fistulas
rather than failed percutaneous interventions.
mah
experience, which highlights opportunities for change that may ulti-In regards to the comparison to first time grafts, we have
submitted an abstract to the Society of Vascular Surgery’s annual
meeting this summer that summarizes the results, but I can give
you a little snapshot. We found that the primary reason a patient
received a graft as opposed to a fistula was due to inadequate vein
size. When we looked at their patency in comparison, primary
patency in the grafts was certainly worse, but secondary patency
after intervention was better at 68% at 1 year. In addition, the
number of interventions performed in the graft group was essen-
tially identical to the number of interventions performed in the
fistula group, and so we achieved better patency results with a
similar intervention rate.
In terms of your question regarding follow-up, there is no
protocol at this time. After surgery, patients are typically seen at
4-week intervals until the fistula is ready for use, so the surgeon is
in charge of ensuring that these fistulas are maturing. We do not
use duplex scanning on a regular basis and rather rely on clinical
examination. If there is any question about whether the fistula will
work, we will proceed with a fistulogram and intervene at that same
setting.
And lastly, in regards to the NKF-DOQI recommendations, I
think that the guidelines should focus on establishing any access
that will be usable in a reasonable amount of time in order to
decrease catheter dependence. It has been shown that catheter
dependence carries significant risks and if we are trying to put
fistulas in every patient in order to achieve a high level of autolo-
gous fistula use, in our experience, we are going to have a signifi-
cant number of patients that are just waiting a long time with a
catheter in place.
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In this series of patients receiving an initial, autogenous arterio-
venous fistula (AVF), the reported primary patency at 1 year (36%) is
low relative to other series. The authors attribute this to an
aggressive approach to the placement of autogenous fistulas. In
concluding, they note that adherence to the Kidney Disease Out-
comes Quality Initiative (K/DOQI) strategy may not result in
increased AVF utilization and may prolong catheter dependence.
While the manuscript describes their experience after publica-
tion of the K/DOQI guidelines, not all elements of the guidelines
were followed. For the placement of an AVF to occur in a timely
manner: (1) patients must have access to the healthcare system; (2)
chronic kidney disease must be recognized by primary providers;
(3) patients must be referred to nephrologists for pre-dialysis care;
and (4) nephrologists must make timely referral for hemodialysis
access assessment and placement. For the patients in this series,
there was a breakdown in one or more of these elements, as 78% of
those referred for placement of first time vascular access were
already dialyzing via central venous catheters.
Once surgical referral occurs, K/DOQI emphasizes the impor-
tance of preoperative vein mapping, arterial assessment, and the
preferred order of access placement to optimize the chance of matur-
ing a functional fistula. Based on current literature and K/DOQI
guidelines, arteries should be at least 2 mm and veins at least 2.5 mm,
in diameter.1,2 The order of preferred AVF placement is radiocephalic
 brachiocephalic brachiobasilic arteriovenous grafts.1
The authors are to be commended for a critical review of theira, Neb
mately impact long-term functional patency. The study indicates that
there is, perhaps, a role for a unified approach to dialysis access. It is
possible that patency may have been adversely impacted by the dis-
parate approach of the 15 surgeons in this group and their lack of
adherence to K/DOQI guidelines. Some of the surgeons proceeded
directly to use of a prosthetic graft when patients were not candidates
for radiocephalic or brachiocephalic fistulas, instead of attempting a
brachiobasilic fistula. Only 76% of patients in this study underwent
preoperativemapping.Despitemapping, veinswith diameters as small
as 1.3 mm were used for fistulas. Even after access had been placed,
times to cannulation seem prolonged.
While we have a limited understanding of why fistulas fail, we
do know that fistulas are more likely to fail when minimum
requirements are not met. A standardized approach is crucial not
only for clinical outcomes, but for our ability to study access
outcomes. The goal is not to simply place an AVF, but to place an
access that can be utilized for hemodialysis.
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